67 filings
Page 2 of 4
FWP
e8df0t
10 Jul 17
Free writing prospectus
12:00am
8-K
zf7vi5lvf ia
26 May 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
33xtig
12 May 17
PhaseRx Reports First Quarter 2017 Financial Results and Provides Corporate Update
12:00am
DEF 14A
r4hpmgs
13 Apr 17
Definitive proxy
12:00am
8-K
6zsdheh8bxkam
27 Mar 17
PhaseRx Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
12:00am
S-8
765ui1l
27 Mar 17
Registration of securities for employees
12:00am
10-K
t4g4i82g
27 Mar 17
Annual report
12:00am
8-K
9frb 7o9gdbktmlb1y
8 Mar 17
Regulation FD Disclosure
12:00am
8-K
adz6lk1hcg7
6 Mar 17
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
ncxzv uikt7
28 Nov 16
PhaseRx Receives Orphan Drug Designation from FDA for PRX-OTC for the Treatment of Ornithine Transcarbamylase Deficiency
12:00am
8-K
nis899fb8
8 Nov 16
Regulation FD Disclosure
12:00am
8-K
g0iyhn8kda0isdvqa
7 Nov 16
PhaseRx Reports Third Quarter 2016 Financial Results and Provides Corporate Update
12:00am
8-K
r4mj5 pkus
24 Aug 16
Departure of Directors or Certain Officers
12:00am
S-8
wd8b6vorgjo3b8 tg0g
12 Aug 16
Registration of securities for employees
12:00am
10-Q
wkcl2a t5h
2 Aug 16
Quarterly report
12:00am